ReP USP - Resultado da busca

Parte de monografia/livro
Structural aspects of organic compounds as proteasome inhibitors addressed to several diseases (2022)
Gomes, Suzane Quintana ; Silva, Guilherme Martins da ; Barcelos, Mariana Pegrucci ; Melim, Lorane Izabel da Silva Hage; Silva, Carlos Henrique Tomich de Paula da
Fonte: Research topics in bioactivity, environment and energy: experimental and theoretical tools. Unidades: FCFRP, FFCLRP
Assuntos: CICLO CELULAR, ARTRITE REUMATOIDE, ASMA, PSORÍASE, MALÁRIA, DOENÇA DE CHAGAS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Suzane Quintana et al. Structural aspects of organic compounds as proteasome inhibitors addressed to several diseases. Research topics in bioactivity, environment and energy: experimental and theoretical tools. Tradução . Cham: Springer, 2022. . Disponível em: https://doi.org/10.1007/978-3-031-07622-0_22. Acesso em: 03 nov. 2024.
APA
Gomes, S. Q., Silva, G. M. da, Barcelos, M. P., Melim, L. I. da S. H., & Silva, C. H. T. de P. da. (2022). Structural aspects of organic compounds as proteasome inhibitors addressed to several diseases. In Research topics in bioactivity, environment and energy: experimental and theoretical tools. Cham: Springer. doi:10.1007/978-3-031-07622-0_22
NLM
Gomes SQ, Silva GM da, Barcelos MP, Melim LI da SH, Silva CHT de P da. Structural aspects of organic compounds as proteasome inhibitors addressed to several diseases [Internet]. In: Research topics in bioactivity, environment and energy: experimental and theoretical tools. Cham: Springer; 2022. [citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/978-3-031-07622-0_22
Vancouver
Gomes SQ, Silva GM da, Barcelos MP, Melim LI da SH, Silva CHT de P da. Structural aspects of organic compounds as proteasome inhibitors addressed to several diseases [Internet]. In: Research topics in bioactivity, environment and energy: experimental and theoretical tools. Cham: Springer; 2022. [citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/978-3-031-07622-0_22
Artigo de periodico
Pharmacophore-based virtual screening from phytocannabinoids as antagonist r-CB1 (2022)
Correia, Lenir Cabral; Ferreira, Jaderson V.; Lima, Henrique B. de; Silva, Guilherme Martins da ; Silva, Carlos Henrique Tomich de Paula da ; Molfetta, Fábio Alberto de; Melim, Lorane Izabel da Silva Hage
Fonte: Journal of Molecular Modeling. Unidades: FCFRP, FFCLRP
Assuntos: CANABINOIDES, TRIAGEM TOXICOLÓGICA, SIMULAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORREIA, Lenir Cabral et al. Pharmacophore-based virtual screening from phytocannabinoids as antagonist r-CB1. Journal of Molecular Modeling, v. 28, n. 9, p. 1-26, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00894-022-05219-3. Acesso em: 03 nov. 2024.
APA
Correia, L. C., Ferreira, J. V., Lima, H. B. de, Silva, G. M. da, Silva, C. H. T. de P. da, Molfetta, F. A. de, & Melim, L. I. da S. H. (2022). Pharmacophore-based virtual screening from phytocannabinoids as antagonist r-CB1. Journal of Molecular Modeling, 28( 9), 1-26. doi:10.1007/s00894-022-05219-3
NLM
Correia LC, Ferreira JV, Lima HB de, Silva GM da, Silva CHT de P da, Molfetta FA de, Melim LI da SH. Pharmacophore-based virtual screening from phytocannabinoids as antagonist r-CB1 [Internet]. Journal of Molecular Modeling. 2022 ; 28( 9): 1-26.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s00894-022-05219-3
Vancouver
Correia LC, Ferreira JV, Lima HB de, Silva GM da, Silva CHT de P da, Molfetta FA de, Melim LI da SH. Pharmacophore-based virtual screening from phytocannabinoids as antagonist r-CB1 [Internet]. Journal of Molecular Modeling. 2022 ; 28( 9): 1-26.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s00894-022-05219-3
Artigo de periodico
Chromatographic profile, in silico and in vivo study of the pharmacokinetic and toxicological properties of major constituent present in kefir, the kefiran (2022)
Barros, Susy Érika de Lima; Lima, Henrique Barros de; Gonçalves, Leandra Karoline Alves; Correia, Lenir Cabral; Brito, Maiara de Fátima de Brito; Barcelos, Mariana Pegrucci ; Silva, Guilherme Martins da ; Silva, Carlos Henrique Tomich de Paula da ; Costa, Rafael Garrett da; Cruz, Rodrigo Alves Soares; Carvalho, José Carlos Tavares; Melim, Lorane Izabel da Silva Hage
Fonte: Toxicology Research. Unidades: FCFRP, FFCLRP
Assuntos: ALIMENTOS FUNCIONAIS, POLISSACARÍDEOS, FARMACOCINÉTICA, LEVEDURAS, BACTÉRIAS LÁTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARROS, Susy Érika de Lima et al. Chromatographic profile, in silico and in vivo study of the pharmacokinetic and toxicological properties of major constituent present in kefir, the kefiran. Toxicology Research, v. 11, n. 3, p. 520-528, 2022Tradução . . Disponível em: https://doi.org/10.1093/toxres/tfac032. Acesso em: 03 nov. 2024.
APA
Barros, S. É. de L., Lima, H. B. de, Gonçalves, L. K. A., Correia, L. C., Brito, M. de F. de B., Barcelos, M. P., et al. (2022). Chromatographic profile, in silico and in vivo study of the pharmacokinetic and toxicological properties of major constituent present in kefir, the kefiran. Toxicology Research, 11( 3), 520-528. doi:10.1093/toxres/tfac032
NLM
Barros SÉ de L, Lima HB de, Gonçalves LKA, Correia LC, Brito M de F de B, Barcelos MP, Silva GM da, Silva CHT de P da, Costa RG da, Cruz RAS, Carvalho JCT, Melim LI da SH. Chromatographic profile, in silico and in vivo study of the pharmacokinetic and toxicological properties of major constituent present in kefir, the kefiran [Internet]. Toxicology Research. 2022 ; 11( 3): 520-528.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1093/toxres/tfac032
Vancouver
Barros SÉ de L, Lima HB de, Gonçalves LKA, Correia LC, Brito M de F de B, Barcelos MP, Silva GM da, Silva CHT de P da, Costa RG da, Cruz RAS, Carvalho JCT, Melim LI da SH. Chromatographic profile, in silico and in vivo study of the pharmacokinetic and toxicological properties of major constituent present in kefir, the kefiran [Internet]. Toxicology Research. 2022 ; 11( 3): 520-528.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1093/toxres/tfac032
Parte de monografia/livro
Lead optimization in drug discovery (2022)
Barcelos, Mariana Pegrucci ; Gomes, Suzane Quintana ; Federico, Leonardo Bruno ; Francischini, Isaque Antônio Galindo ; Melim, Lorane Izabel da Silva Hage; Silva, Guilherme Martins da ; Silva, Carlos Henrique Tomich de Paula da
Fonte: Research topics in bioactivity, environment and energy: experimental and theoretical tools. Unidades: FCFRP, FFCLRP
Assuntos: PLANEJAMENTO DE FÁRMACOS, LEAD, QUÍMICA FARMACÊUTICA, LIGANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARCELOS, Mariana Pegrucci et al. Lead optimization in drug discovery. Research topics in bioactivity, environment and energy: experimental and theoretical tools. Tradução . Cham: Springer, 2022. . Disponível em: https://doi.org/10.1007/978-3-031-07622-0_19. Acesso em: 03 nov. 2024.
APA
Barcelos, M. P., Gomes, S. Q., Federico, L. B., Francischini, I. A. G., Melim, L. I. da S. H., Silva, G. M. da, & Silva, C. H. T. de P. da. (2022). Lead optimization in drug discovery. In Research topics in bioactivity, environment and energy: experimental and theoretical tools. Cham: Springer. doi:10.1007/978-3-031-07622-0_19
NLM
Barcelos MP, Gomes SQ, Federico LB, Francischini IAG, Melim LI da SH, Silva GM da, Silva CHT de P da. Lead optimization in drug discovery [Internet]. In: Research topics in bioactivity, environment and energy: experimental and theoretical tools. Cham: Springer; 2022. [citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/978-3-031-07622-0_19
Vancouver
Barcelos MP, Gomes SQ, Federico LB, Francischini IAG, Melim LI da SH, Silva GM da, Silva CHT de P da. Lead optimization in drug discovery [Internet]. In: Research topics in bioactivity, environment and energy: experimental and theoretical tools. Cham: Springer; 2022. [citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/978-3-031-07622-0_19
Artigo de periodico
Molecular docking, physicochemical properties, pharmacokinetics and toxicity of flavonoids present in Euterpe oleracea Martius (2021)
Oliveira, Nayana Keyla Seabra de; Almeida, Marcos Rafael Silva; Pontes, Franco Márcio Maciel; Barcelos, Mariana Pegrucci ; Silva, Guilherme Martins da ; Silva, Carlos Henrique Tomich de Paula da ; Cruz, Rodrigo Alves Soares; Melim, Lorane Izabel da Silva Hage
Fonte: Current Computer-Aided Drug Design. Unidades: FCFRP, FFCLRP
Assuntos: AÇAÍ, FLAVONOIDES, ANTIOXIDANTES, POLIFENÓIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Nayana Keyla Seabra de et al. Molecular docking, physicochemical properties, pharmacokinetics and toxicity of flavonoids present in Euterpe oleracea Martius. Current Computer-Aided Drug Design, v. 17, n. 4, p. 589-617, 2021Tradução . . Disponível em: https://doi.org/10.2174/1573409916666200619122803. Acesso em: 03 nov. 2024.
APA
Oliveira, N. K. S. de, Almeida, M. R. S., Pontes, F. M. M., Barcelos, M. P., Silva, G. M. da, Silva, C. H. T. de P. da, et al. (2021). Molecular docking, physicochemical properties, pharmacokinetics and toxicity of flavonoids present in Euterpe oleracea Martius. Current Computer-Aided Drug Design, 17( 4), 589-617. doi:10.2174/1573409916666200619122803
NLM
Oliveira NKS de, Almeida MRS, Pontes FMM, Barcelos MP, Silva GM da, Silva CHT de P da, Cruz RAS, Melim LI da SH. Molecular docking, physicochemical properties, pharmacokinetics and toxicity of flavonoids present in Euterpe oleracea Martius [Internet]. Current Computer-Aided Drug Design. 2021 ; 17( 4): 589-617.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2174/1573409916666200619122803
Vancouver
Oliveira NKS de, Almeida MRS, Pontes FMM, Barcelos MP, Silva GM da, Silva CHT de P da, Cruz RAS, Melim LI da SH. Molecular docking, physicochemical properties, pharmacokinetics and toxicity of flavonoids present in Euterpe oleracea Martius [Internet]. Current Computer-Aided Drug Design. 2021 ; 17( 4): 589-617.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2174/1573409916666200619122803
Artigo de periodico
Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening (2021)
Federico, Leonardo Bruno ; Silva, Guilherme Martins da ; Melim, Lorane Izabel da Silva Hage; Gomes, Suzane Quintana ; Barcelos, Mariana Pegrucci ; Francischini, Isaque Antônio Galindo ; Silva, Carlos Henrique Tomich de Paula da
Fonte: Future Medicinal Chemistry. Unidades: FCFRP, FFCLRP
Assuntos: ANTIVIRAIS, MEDICAMENTO, COVID-19, BANCO DE DADOS, AVALIAÇÃO DE MEDICAMENTOS, ESTRUTURA MOLECULAR (QUÍMICA TEÓRICA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FEDERICO, Leonardo Bruno et al. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening. Future Medicinal Chemistry, v. 13, n. 16, p. 1353-1366, 2021Tradução . . Disponível em: https://doi.org/10.4155/fmc-2021-0025. Acesso em: 03 nov. 2024.
APA
Federico, L. B., Silva, G. M. da, Melim, L. I. da S. H., Gomes, S. Q., Barcelos, M. P., Francischini, I. A. G., & Silva, C. H. T. de P. da. (2021). Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening. Future Medicinal Chemistry, 13( 16), 1353-1366. doi:10.4155/fmc-2021-0025
NLM
Federico LB, Silva GM da, Melim LI da SH, Gomes SQ, Barcelos MP, Francischini IAG, Silva CHT de P da. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening [Internet]. Future Medicinal Chemistry. 2021 ; 13( 16): 1353-1366.[citado 2024 nov. 03 ] Available from: https://doi.org/10.4155/fmc-2021-0025
Vancouver
Federico LB, Silva GM da, Melim LI da SH, Gomes SQ, Barcelos MP, Francischini IAG, Silva CHT de P da. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening [Internet]. Future Medicinal Chemistry. 2021 ; 13( 16): 1353-1366.[citado 2024 nov. 03 ] Available from: https://doi.org/10.4155/fmc-2021-0025
Artigo de periodico
Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease (2020)
Souza, Lucilene R.; Picanço, Leide C. S.; Brito, Maiara F. B.; Almeida, Marcos R. S.; Marino, Bianca L. B.; Sousa, Kessia P. A.; Ferreira, Jaderson V.; Santos, Cleydson B. R.; Silva, Guilherme Martins da ; Silva, Carlos Henrique Tomich de Paula da ; Taft, Carlton A.; Melim, Lorane Izabel da Silva Hage
Fonte: Central Nervous System Agents in Medicinal Chemistry. Unidades: FCFRP, FFCLRP
Assuntos: FARMACOCINÉTICA, DOENÇA DE PARKINSON, PLANEJAMENTO DE FÁRMACOS, FÁRMACOS (SISTEMA NERVOSO CENTRAL), RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Lucilene R. et al. Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease. Central Nervous System Agents in Medicinal Chemistry, v. 20, n. 2, p. 128-143, 2020Tradução . . Disponível em: https://doi.org/10.2174/1871524920666200217110211. Acesso em: 03 nov. 2024.
APA
Souza, L. R., Picanço, L. C. S., Brito, M. F. B., Almeida, M. R. S., Marino, B. L. B., Sousa, K. P. A., et al. (2020). Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease. Central Nervous System Agents in Medicinal Chemistry, 20( 2), 128-143. doi:10.2174/1871524920666200217110211
NLM
Souza LR, Picanço LCS, Brito MFB, Almeida MRS, Marino BLB, Sousa KPA, Ferreira JV, Santos CBR, Silva GM da, Silva CHT de P da, Taft CA, Melim LI da SH. Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease [Internet]. Central Nervous System Agents in Medicinal Chemistry. 2020 ; 20( 2): 128-143.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2174/1871524920666200217110211
Vancouver
Souza LR, Picanço LCS, Brito MFB, Almeida MRS, Marino BLB, Sousa KPA, Ferreira JV, Santos CBR, Silva GM da, Silva CHT de P da, Taft CA, Melim LI da SH. Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease [Internet]. Central Nervous System Agents in Medicinal Chemistry. 2020 ; 20( 2): 128-143.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2174/1871524920666200217110211
Artigo de periodico
Parkinson’s disease: a review from pathophysiology to treatment (2020)
Marino, Bianca L. B.; Souza, Lucilene R.; Sousa, Kessia P. A.; Ferreira, Jaderson V.; Padilha, Elias Carvalho; Silva, Carlos Henrique Tomich de Paula da ; Taft, Carlton A.; Melim, Lorane Izabel da Silva Hage
Fonte: Mini-Reviews in Medicinal Chemistry. Unidade: FCFRP
Assuntos: BIOMARCADORES, COLINÉRGICOS, EXPECTATIVAS, ESTRESSE OXIDATIVO, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARINO, Bianca L. B. et al. Parkinson’s disease: a review from pathophysiology to treatment. Mini-Reviews in Medicinal Chemistry, v. 20, n. 9, p. 754-767, 2020Tradução . . Disponível em: https://doi.org/10.2174/1389557519666191104110908. Acesso em: 03 nov. 2024.
APA
Marino, B. L. B., Souza, L. R., Sousa, K. P. A., Ferreira, J. V., Padilha, E. C., Silva, C. H. T. de P. da, et al. (2020). Parkinson’s disease: a review from pathophysiology to treatment. Mini-Reviews in Medicinal Chemistry, 20( 9), 754-767. doi:10.2174/1389557519666191104110908
NLM
Marino BLB, Souza LR, Sousa KPA, Ferreira JV, Padilha EC, Silva CHT de P da, Taft CA, Melim LI da SH. Parkinson’s disease: a review from pathophysiology to treatment [Internet]. Mini-Reviews in Medicinal Chemistry. 2020 ; 20( 9): 754-767.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2174/1389557519666191104110908
Vancouver
Marino BLB, Souza LR, Sousa KPA, Ferreira JV, Padilha EC, Silva CHT de P da, Taft CA, Melim LI da SH. Parkinson’s disease: a review from pathophysiology to treatment [Internet]. Mini-Reviews in Medicinal Chemistry. 2020 ; 20( 9): 754-767.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2174/1389557519666191104110908
Artigo de periodico
Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study (2020)
Castro, Leandro L.; Picanço, Leide C. S.; Silva, Jaderson V.; Souza, Lucilene R.; Sousa, Kessia P. A.; Pinheiro, Abraão A.; Chaves, Gisele A.; Teixeira, Hueldem R. C.; Silva, Guilherme Martins da ; Taft, Carlton A.; Silva, Carlos Henrique Tomich de Paula da ; Melim, Lorane Izabel da Silva Hage
Fonte: Current Computer-Aided Drug Design. Unidades: FCFRP, FFCLRP
Assuntos: DOENÇA DE ALZHEIMER, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS, INIBIDORES DE ENZIMAS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Leandro L. et al. Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study. Current Computer-Aided Drug Design, v. 16, n. 5, p. 541-554, 2020Tradução . . Disponível em: https://doi.org/10.2174/1573409915666191015110734. Acesso em: 03 nov. 2024.
APA
Castro, L. L., Picanço, L. C. S., Silva, J. V., Souza, L. R., Sousa, K. P. A., Pinheiro, A. A., et al. (2020). Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study. Current Computer-Aided Drug Design, 16( 5), 541-554. doi:10.2174/1573409915666191015110734
NLM
Castro LL, Picanço LCS, Silva JV, Souza LR, Sousa KPA, Pinheiro AA, Chaves GA, Teixeira HRC, Silva GM da, Taft CA, Silva CHT de P da, Melim LI da SH. Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study [Internet]. Current Computer-Aided Drug Design. 2020 ; 16( 5): 541-554.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2174/1573409915666191015110734
Vancouver
Castro LL, Picanço LCS, Silva JV, Souza LR, Sousa KPA, Pinheiro AA, Chaves GA, Teixeira HRC, Silva GM da, Taft CA, Silva CHT de P da, Melim LI da SH. Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study [Internet]. Current Computer-Aided Drug Design. 2020 ; 16( 5): 541-554.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2174/1573409915666191015110734
Artigo de periodico
In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs (2019)
Melim, Lorane Izabel da Silva Hage ; Poiani, João Gabriel Curtolo ; Silva, Carlos Henrique Tomich de Paula da ; Boylan, Fábio
Fonte: Food and Chemical Toxicology. Unidade: FCFRP
Assuntos: ANTI-INFLAMATÓRIOS, ANSIOLÍTICOS, ANTIDEPRESSIVOS, ANTI-HISTAMÍNICOS H1
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELIM, Lorane Izabel da Silva Hage et al. In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs. Food and Chemical Toxicology, v. 131, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.fct.2019.06.003. Acesso em: 03 nov. 2024.
APA
Melim, L. I. da S. H., Poiani, J. G. C., Silva, C. H. T. de P. da, & Boylan, F. (2019). In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs. Food and Chemical Toxicology, 131. doi:10.1016/j.fct.2019.06.003
NLM
Melim LI da SH, Poiani JGC, Silva CHT de P da, Boylan F. In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs [Internet]. Food and Chemical Toxicology. 2019 ; 131[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.fct.2019.06.003
Vancouver
Melim LI da SH, Poiani JGC, Silva CHT de P da, Boylan F. In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs [Internet]. Food and Chemical Toxicology. 2019 ; 131[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.fct.2019.06.003
Artigo de periodico
Antioxidant effect of flavonoids present in Euterpe oleracea martius and neurodegenerative diseases: a literature review (2019)
Oliveira, Nayana Keyla Seabra de; Almeida, Marcos Rafael Silva; Pontes, Franco Márcio Maciel; Barcelos, Mariana Pegrucci ; Silva, Carlos Henrique Tomich de Paula da ; Rosa, Joaquin Maria Campos; Cruz, Rodrigo Alves Soares; Melim, Lorane Izabel da Silva Hage
Fonte: Central Nervous System Agents in Medicinal Chemistry. Unidades: FCFRP, FFCLRP
Assuntos: AÇAÍ, DOENÇA DE ALZHEIMER, ANTIOXIDANTES, FLAVONOIDES, DOENÇAS NEURODEGENERATIVAS, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Nayana Keyla Seabra de et al. Antioxidant effect of flavonoids present in Euterpe oleracea martius and neurodegenerative diseases: a literature review. Central Nervous System Agents in Medicinal Chemistry, v. 19, n. 2, p. 75-99, 2019Tradução . . Disponível em: https://doi.org/10.2174/1871524919666190502105855. Acesso em: 03 nov. 2024.
APA
Oliveira, N. K. S. de, Almeida, M. R. S., Pontes, F. M. M., Barcelos, M. P., Silva, C. H. T. de P. da, Rosa, J. M. C., et al. (2019). Antioxidant effect of flavonoids present in Euterpe oleracea martius and neurodegenerative diseases: a literature review. Central Nervous System Agents in Medicinal Chemistry, 19( 2), 75-99. doi:10.2174/1871524919666190502105855
NLM
Oliveira NKS de, Almeida MRS, Pontes FMM, Barcelos MP, Silva CHT de P da, Rosa JMC, Cruz RAS, Melim LI da SH. Antioxidant effect of flavonoids present in Euterpe oleracea martius and neurodegenerative diseases: a literature review [Internet]. Central Nervous System Agents in Medicinal Chemistry. 2019 ; 19( 2): 75-99.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2174/1871524919666190502105855
Vancouver
Oliveira NKS de, Almeida MRS, Pontes FMM, Barcelos MP, Silva CHT de P da, Rosa JMC, Cruz RAS, Melim LI da SH. Antioxidant effect of flavonoids present in Euterpe oleracea martius and neurodegenerative diseases: a literature review [Internet]. Central Nervous System Agents in Medicinal Chemistry. 2019 ; 19( 2): 75-99.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2174/1871524919666190502105855
Artigo de periodico
Allosteric modulators of potential targets related to Alzheimer's disease: a review (2019)
Silva, Guilherme Martins da ; Barcelos, Mariana Pegrucci ; Poiani, João Gabriel Curtolo ; Melim, Lorane Izabel da Silva Hage ; Silva, Carlos Henrique Tomich de Paula da
Fonte: ChemMedChem. Unidades: FCFRP, FFCLRP
Assuntos: DOENÇA DE ALZHEIMER, REGULAÇÃO ALOSTÉRICA, LIGANTES, RECEPTORES DE SUPERFÍCIE CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Guilherme Martins da et al. Allosteric modulators of potential targets related to Alzheimer's disease: a review. ChemMedChem, v. 14, n. 16, p. 1467-1483, 2019Tradução . . Disponível em: https://doi.org/10.1002/cmdc.201900299. Acesso em: 03 nov. 2024.
APA
Silva, G. M. da, Barcelos, M. P., Poiani, J. G. C., Melim, L. I. da S. H., & Silva, C. H. T. de P. da. (2019). Allosteric modulators of potential targets related to Alzheimer's disease: a review. ChemMedChem, 14( 16), 1467-1483. doi:10.1002/cmdc.201900299
NLM
Silva GM da, Barcelos MP, Poiani JGC, Melim LI da SH, Silva CHT de P da. Allosteric modulators of potential targets related to Alzheimer's disease: a review [Internet]. ChemMedChem. 2019 ; 14( 16): 1467-1483.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1002/cmdc.201900299
Vancouver
Silva GM da, Barcelos MP, Poiani JGC, Melim LI da SH, Silva CHT de P da. Allosteric modulators of potential targets related to Alzheimer's disease: a review [Internet]. ChemMedChem. 2019 ; 14( 16): 1467-1483.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1002/cmdc.201900299
Trabalho de evento-resumo
Phospholipases 'A IND.2' inhibitors: homology modeling, virtual screening and protein-ligand docking (2007)
Melim, Lorane Izabel da Silva Hage; Semighini, Evandro Pizeta; Silva, Carlos Henrique Tomich de Paula da; Sampaio, Suely Vilela
Fonte: Abstract. Nome do evento: International Congress of Pharmaceutical Sciences (CIFARP). Unidade: FCFRP
Assunto: VENENOS DE ORIGEM ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELIM, Lorane Izabel da Silva Hage et al. Phospholipases 'A IND.2' inhibitors: homology modeling, virtual screening and protein-ligand docking. 2007, Anais.. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 2007. . Acesso em: 03 nov. 2024.
APA
Melim, L. I. da S. H., Semighini, E. P., Silva, C. H. T. de P. da, & Sampaio, S. V. (2007). Phospholipases 'A IND.2' inhibitors: homology modeling, virtual screening and protein-ligand docking. In Abstract. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo.
NLM
Melim LI da SH, Semighini EP, Silva CHT de P da, Sampaio SV. Phospholipases 'A IND.2' inhibitors: homology modeling, virtual screening and protein-ligand docking. Abstract. 2007 ;[citado 2024 nov. 03 ]
Vancouver
Melim LI da SH, Semighini EP, Silva CHT de P da, Sampaio SV. Phospholipases 'A IND.2' inhibitors: homology modeling, virtual screening and protein-ligand docking. Abstract. 2007 ;[citado 2024 nov. 03 ]
Trabalho de evento-resumo
Partial primary structure characterization, theoretical model and biological activity of snake venom lectin (galatrox) from Bothrops atrox (2007)
Franqueiro, Elaine de Paula Mendonça; Alves, Raquel de Melo; Franco, João José; Rosa, José César; Alves, Raquel de Melo; Franco, João José; Melim, Lorane Izabel da Silva Hage; Silva, Carlos Henrique Tomich de Paula da; Baruffi, Marcelo Dias; Sampaio, Suely Vilela
Fonte: Abstract. Nome do evento: International Congress of Pharmaceutical Sciences (CIFARP). Unidades: FCFRP, FMRP
Assunto: VENENOS DE ORIGEM ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANQUEIRO, Elaine de Paula Mendonça et al. Partial primary structure characterization, theoretical model and biological activity of snake venom lectin (galatrox) from Bothrops atrox. 2007, Anais.. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 2007. . Acesso em: 03 nov. 2024.
APA
Franqueiro, E. de P. M., Alves, R. de M., Franco, J. J., Rosa, J. C., Alves, R. de M., Franco, J. J., et al. (2007). Partial primary structure characterization, theoretical model and biological activity of snake venom lectin (galatrox) from Bothrops atrox. In Abstract. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo.
NLM
Franqueiro E de PM, Alves R de M, Franco JJ, Rosa JC, Alves R de M, Franco JJ, Melim LI da SH, Silva CHT de P da, Baruffi MD, Sampaio SV. Partial primary structure characterization, theoretical model and biological activity of snake venom lectin (galatrox) from Bothrops atrox. Abstract. 2007 ;[citado 2024 nov. 03 ]
Vancouver
Franqueiro E de PM, Alves R de M, Franco JJ, Rosa JC, Alves R de M, Franco JJ, Melim LI da SH, Silva CHT de P da, Baruffi MD, Sampaio SV. Partial primary structure characterization, theoretical model and biological activity of snake venom lectin (galatrox) from Bothrops atrox. Abstract. 2007 ;[citado 2024 nov. 03 ]

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Título da fonte

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada